miR-486-5p expression is regulated by DNA methylation in osteosarcoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-486-5p expression is regulated by DNA methylation in osteosarcoma
Authors
Keywords
-
Journal
BMC GENOMICS
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-17
DOI
10.1186/s12864-022-08346-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma
- (2020) Christopher E. Lietz et al. Scientific Reports
- Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
- (2020) Claudia Maria Hattinger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparative analysis of genome-wide DNA methylation identifies patterns that associate with conserved transcriptional programs in osteosarcoma
- (2020) Lauren J. Mills et al. BONE
- MiR-486-5p inhibits the proliferation of leukemia cells and induces apoptosis through targeting FOXO1
- (2019) Hui Liu et al. MOLECULAR AND CELLULAR PROBES
- The roles of DNA, RNA and histone methylation in ageing and cancer
- (2019) Ewa M. Michalak et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The roles of microRNAs in epigenetic regulation
- (2019) Qian Yao et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- An update on emerging drugs in osteosarcoma: towards tailored therapies?
- (2019) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas
- (2019) Naofumi Asano et al. Scientific Reports
- Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms
- (2018) Chunmei Li et al. BMC CANCER
- miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1
- (2018) Hanyu Liu et al. Cancer Biomarkers
- Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?
- (2018) Claudia Maria Hattinger et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Clinical epigenetics: seizing opportunities for translation
- (2018) María Berdasco et al. NATURE REVIEWS GENETICS
- DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways
- (2018) Xiangxiang Liu et al. Cell Death & Disease
- miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
- (2017) Ming He et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma
- (2017) Sam Behjati et al. Nature Communications
- The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways
- (2017) Yang Yang et al. Oncotarget
- Altered MicroRNA Expression Is Responsible for the Pro‐Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves
- (2017) Rui Song et al. Journal of the American Heart Association
- Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma
- (2016) Jingmin Shu et al. Oncotarget
- Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
- (2015) Michal Kovac et al. Nature Communications
- Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations
- (2015) Susanne Lorenz et al. Oncotarget
- Distinct Pathways in the Pathogenesis of Sebaceous Carcinomas Implicated by Differentially Expressed MicroRNAs
- (2015) Michael T. Tetzlaff et al. JAMA Ophthalmology
- MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome
- (2014) L. Shaham et al. BLOOD
- MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1
- (2014) Xin-Ping Huang et al. FEBS Journal
- Epigenetic alterations in osteosarcoma: promising targets
- (2014) Binghao Li et al. MOLECULAR BIOLOGY REPORTS
- Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
- (2014) Katie Lunnon et al. NATURE NEUROSCIENCE
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
- (2014) Jennifer A. Perry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells
- (2014) Guoqiang Zhang et al. TUMOR BIOLOGY
- Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes
- (2013) S U Lauvrak et al. BRITISH JOURNAL OF CANCER
- Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer
- (2013) Y. Peng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma
- (2012) Nariso Borjigin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma
- (2012) K. B. Jones et al. CANCER RESEARCH
- Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
- (2012) Heidi M. Namløs et al. PLoS One
- Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
- (2012) Stine H. Kresse et al. PLoS One
- Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations
- (2011) Stine H. Kresse et al. CANCER
- Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer
- (2011) H.-K. Oh et al. CLINICAL CANCER RESEARCH
- Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
- (2011) Guro E Lind et al. Molecular Cancer
- Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma
- (2011) Georges Maire et al. Cancer Genetics
- A potential role for intragenic miRNAs on their hosts' interactome
- (2010) Ludwig Hinske et al. BMC GENOMICS
- Tissue-Specific and Ubiquitous Expression Patterns from Alternative Promoters of Human Genes
- (2010) Edwin Jacox et al. PLoS One
- Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486
- (2010) E. M. Small et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Tissue Microarray Study of Osteosarcoma: Histopathologic and Immunohistochemical Validation of Xenotransplanted Tumors as Preclinical Models
- (2010) Empar Mayordomo et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort
- (2009) Laura Ottaviano et al. GENES CHROMOSOMES & CANCER
- Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling
- (2009) Bekim Sadikovic et al. HUMAN MOLECULAR GENETICS
- Hypermethylated MAL gene – a silent marker of early colon tumorigenesis
- (2008) Guro E Lind et al. Journal of Translational Medicine
- DNA methylation landscapes: provocative insights from epigenomics
- (2008) Miho M. Suzuki et al. NATURE REVIEWS GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started